000 01452 a2200397 4500
005 20250517191214.0
264 0 _c20190614
008 201906s 0 0 eng d
022 _a2373-8227
024 7 _a10.1021/acsinfecdis.7b00254
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aThamban Chandrika, Nishad
245 0 0 _aNew Application of Neomycin B-Bisbenzimidazole Hybrids as Antifungal Agents.
_h[electronic resource]
260 _bACS infectious diseases
_c02 2018
300 _a196-207 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
650 0 4 _aAntifungal Agents
_xchemistry
650 0 4 _aBiofilms
_xdrug effects
650 0 4 _aBisbenzimidazole
_xchemistry
650 0 4 _aCandida albicans
_xdrug effects
650 0 4 _aDose-Response Relationship, Drug
650 0 4 _aFramycetin
_xchemistry
650 0 4 _aHemolysis
650 0 4 _aMicrobial Sensitivity Tests
650 0 4 _aMolecular Structure
650 0 4 _aReactive Oxygen Species
_xmetabolism
650 0 4 _aSterols
_xchemistry
650 0 4 _aTime Factors
700 1 _aShrestha, Sanjib K
700 1 _aRanjan, Nihar
700 1 _aSharma, Anindra
700 1 _aArya, Dev P
700 1 _aGarneau-Tsodikova, Sylvie
773 0 _tACS infectious diseases
_gvol. 4
_gno. 2
_gp. 196-207
856 4 0 _uhttps://doi.org/10.1021/acsinfecdis.7b00254
_zAvailable from publisher's website
999 _c27875766
_d27875766